Edwards Lifesciences Corporation (EW)
NYSE
Closed
Aug 21, 2026
Day's Range
88.7952 wk Range
72.30Overview - EW - Edwards Lifesciences Corporation
Key Statistics
Valuation
Enterprise Value
48.31B
P/E (Trailing)
‪53.44‬
P/E (Forward)
‪26.58‬
PEG Ratio
‪-2.03‬
Price / Sales (TTM)
‪7.94‬
Price / Book
‪4.87‬
EV / EBITDA
‪24.19‬
Profitability
Gross Margin
‪77.46%‬
Profit Margin
‪15.43%‬
Operating Margin
‪29.83%‬
Return on Assets
‪8.36%‬
Return on Equity
‪9.17%‬
Ownership
Shares Outstanding
576.60M
Float
574.49M
Short % of Shares Outstanding
‪1.98%‬
Held by Insiders
‪0.19%‬
Held by Institutions
‪97.11%‬
Price stats
Beta
‪0.84‬
50-Day Avg
‪88.99‬
200-Day Avg
‪84.65‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
28 analysts
Average price target
‪$ 100.96‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - EW - Edwards Lifesciences Corporation
Peers - EW - Edwards Lifesciences Corporation
Peer Comparison
Compared with companies in Medical Devices listed on NYSE.
- EWNYSEEdwards Lifesciences Corporation51.75BMarket Cap+9.95%52-week change55.11P/E (Trailing)‪15.43%‬Profit Margin
- CVXNYSEChevron Corporation402.65BMarket Cap+22.93%52-week change19.76P/E (Trailing)‪9.83%‬Profit Margin
- ABTNYSEAbbott Laboratories203.16BMarket Cap-13.06%52-week change37.63P/E (Trailing)‪11.64%‬Profit Margin
- SYKNYSEStryker Corporation126.36BMarket Cap-18.65%52-week change34.14P/E (Trailing)‪14.43%‬Profit Margin
- MDTNYSEMedtronic plc119.48BMarket Cap+1.40%52-week change25.03P/E (Trailing)‪13.20%‬Profit Margin
- ICENYSEIntercontinental Exchange, Inc.90.52BMarket Cap-11.10%52-week change22.71P/E (Trailing)‪38.24%‬Profit Margin
- BSXNYSEBoston Scientific Corporation72.99BMarket Cap-108.68%52-week change20.39P/E (Trailing)‪17.49%‬Profit Margin
Profile Summary - EW - Edwards Lifesciences Corporation
About
Edwards Lifesciences Corporation is a medical technology company focused on structural heart disease and advanced cardiovascular care. The company develops and markets transcatheter heart valve replacement systems, surgical heart valves, and repair technologies used in procedures for aortic, mitral, and tricuspid…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
